Pharmacokinetics of Intranasal Ketorolac in Children
Status:
Terminated
Trial end date:
2017-11-29
Target enrollment:
Participant gender:
Summary
Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) that is typically given to both
adults and children by the intravenous (IV) or intramuscular (IM) route for analgesic
purposes. Ketorolac can also be given by the intranasal (IN) route using a mucosal
atomization device (MAD). We aim to study the pharmacokinetics of ketorolac when administered
by the IN route using the MAD.